Iloprost attenuates doxorubicin-induced cardiac injury in a murine model without compromising tumor suppression.
Kuramochi
Yukio
Y
Takagi
Hisato
H
Morita
Toshisada
T
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D009202:Cardiomyopathies / Q000139:chemically induced*; D016923:Cell Death; D004317:Doxorubicin / Q000009:adverse effects*; D004347:Drug Interactions; D016285:Iloprost / Q000494:pharmacology*; D051379:Mice; D014665:Vasodilator Agents / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D014665:Vasodilator Agents; D004317:Doxorubicin; D016285:Iloprost